Factor Investing: The Tilt That Works If You Can Hold It

You hold the index. Should you tilt?

You already own a broad index fund. Then a backtest crosses your feed: value, or momentum, or quality, beating the market by a few points a year for decades. Same passive discipline as before, only with a smarter ETF and a bit more return. Should you tilt?

The premium is real in the data. Yet almost nobody captures it. The research holds up fine; what defeats people is holding on. Tilting means years of watching the plain index win while your bet bleeds. The premium pays out over a decade, and most investors sell long before it arrives.

Whether you should tilt is really a question about your own staying power. So start with what you'd be buying.

What a factor actually is

A factor is a shared trait that explains why some stocks return more than others. Fama and French (1992, 1993) showed that beyond plain market exposure, two characteristics did persistent work: small companies (size) and cheap-relative-to-fundamentals companies (value). Carhart (1997) added momentum, the tendency of recent winners to keep winning for a while. Fama and French extended their own model in 2015 to include profitability and investment discipline, which the industry markets as quality.

The five that the ETF world actually packages:

• Value (VLUE): cheap stocks on price-to-book, price-to-earnings, and similar ratios.
• Momentum (MTUM): stocks with strong recent 6-to-12-month returns.
• Quality (QUAL): high profitability, low debt, stable earnings.
• Size (SIZE): a tilt toward smaller companies.
• Low volatility (USMV): stocks that move less than the market, which have historically delivered competitive returns at lower risk.

These funds follow mechanical index rules; no manager picks the stocks. iShares' MSCI USA factor suite charges 0.15%. That undercuts the ~0.65% a typical active US equity fund takes, but it's still five times the 0.03% of a plain S&P 500 fund. You pay a small premium for a transparent, rules-based tilt.

One thing the marketing blurs: dividend yield is not on this list. High-dividend funds get sold as a factor, but a dividend tilt is just a noisy proxy for value and quality, the two factors that do the real work. The Fama-French framework gives it no compensated premium of its own. A high payout tells you about a company's distribution policy. It says nothing about expected return.

The premium shrinks once everyone knows

Your instinct should be suspicion: if a money-making pattern is sitting in a published paper, hasn't the crowd already traded it away? Partly, it has. McLean and Pontiff (2016) tracked 97 stock-return predictors from academic papers and measured what happened after each one was published. Returns ran 26% lower out-of-sample and 58% lower after publication. Once a factor gets named and wrapped in an ETF, buyers pile in and compete away a chunk of what made it work.

This doesn't kill factor premia, but it caps what you should expect. The mid-single-digit annual edge in the brochure comes from a backtest run before the crowd showed up. Going forward the edge is thinner, and the fee plus the trading costs of a momentum or value strategy eat into what's left. A small premium after costs is still worth having. It just won't look like the headline backtest.

The decade nobody can sit through

Worse, you can't time the rotation. Factors take turns, and nobody reliably calls which one leads next. Value spent most of the 2010s being punished. Cliff Asness of AQR, who runs real money on these strategies, documented in 2020 that value had grown cheaper relative to growth than at almost any point in the prior 50 years, the dot-com peak included. The drawdown over that decade was the worst on record.

Picture holding a value ETF through that. Ten years of watching a plain index pull ahead while the strategy you tilted toward bled relative performance. The math said value was historically cheap and due. Almost nobody held on to find out. That is the real cost of factor investing, and no fund disclosure prints it: the premium is your reward for sitting through stretches long enough to make you quit at the bottom.

You can see the flinch in the fund flows. SIZE, the iShares size-factor ETF, holds about $422M. Its siblings QUAL and VLUE hold $47B and $16B. Investors pour into whichever factor has felt good lately and starve the rest. That's the exact opposite of what a patience premium rewards.

How you'd actually use a tilt

Factor investing is defensible as a deliberate, sized tilt around a low-cost core. It shouldn't be the core itself. If you go this route, a few things separate a real tilt from a fee-paying detour:

Size it to matter and to survive. A 5% sleeve won't move your returns enough to justify the tracking pain. Go to 10% or more of your equities: big enough to count, and big enough that you'll have to mean it when it lags. How many funds that implies depends on your portfolio size.

Spread the tilt across factors; don't bet on one. Because factors zig and zag at different times, a multifactor fund like VFMF or an equal split across value, momentum, and quality smooths the drought any single factor will eventually hand you.

Keep it cheap and hold it. The edge is thin after publication decay and fees, so a 0.50% "enhanced" factor product can cost more than the premium it chases. You can sort the screener by expense ratio to see how wide the range runs. And don't confuse a factor with a narrow thematic fund — a quality tilt is a diversified rules-based bet on a documented premium, while a thematic ETF is a story sold near its peak.

If none of that sounds like you, that's a real answer too. A plain global index held forever captures the market return without asking you to outlast a decade of relative pain. The factor premium rewards conviction and patience. Without both, you'll pay the fee and sell the tilt before the premium ever shows up.